Loading data for PRE — first visit, this takes a few seconds.

Prenetics Global Limited

NasdaqGM: PRE · Real-Time Price · USD
25.81
-0.44 (-1.68%)
At close: Sep 02, 2026, 8:00 PM
26.43
+1.46%
After-hours: 5:24 PM

The price, the headline numbers and the latest news, in one place.

Prenetics Global Limited (PRE) Stock Price, Analysis & Data

No data available

Bid13.72
Market Cap437M
Revenue (ttm)155M
Net Income (ttm)-56M
0.25
-3.46
n/a
-9.74
P/B (ttm)4.84
P/S (ttm)2.83
Earnings DateNov 10, 2026
Ask23.43
Volume181,521
Avg. Volume (20D)234,446
Open26.46
Previous Close26.25
Day's Range25.01 - 26.46
52-Week Range7.80 - 26.70
Analystn/a
Price Targetn/a
Dividendsn/a
Ex-Dividend Daten/a

About PRE

Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong K...

IPO Date Jul 16, 2021
Employees 98
Stock Exchange NasdaqGM
Ticker Symbol PRE
Full Company Profile

Financial Performance

In 2025, Prenetics Global's revenue was 92.39M, an increase of 479.76% compared to the previous year's 15.94M. Earnings were -37.71M, a decrease of -18.56%.

Financial Statements

Earnings Surprise

Prenetics Global has released their quarterly earnings on Aug 18, 2026:
  • Revenue of $35.95M misses estimates by $0, with 334.49% YoY growth.
  • EPS of -0.52 misses estimates by -0.04, with 44.68% YoY growth.
Prenetics Global Limited is scheduled to release its earnings on Nov 10, 2026, before market opens.
Analysts project revenue of ... Upgrade